Leading pharmaceutical innovators are seeking to evolve their products and development processes with ever improving safety and qualify at a lower cost. This is the key challenge for the industry.
Our goal in Malvern Panalytical is to ease and improve our customers’ workflows so that better products can be developed more quickly and efficiently.
With this in mind, we have introduced a set of webinars aimed at helping pharmaceutical customers improve and simplify their selection of analytical methods for materials characterization.
Please register your interest in these events below!
Series 1 - Focus on Pharma - Particle Sizing
This webinar series we will consider why particle size is important for pharmaceutical products and how answering this question can lead to the specification of a realistic method.
- Advance your Analysis (recorded)
In this presentation we considered why a particle size specification may be required, reviewed the guidance provided in ICH Q6A and then considered how techniques such as laser diffraction and automated image analysis can aid formulation developers in material selection and in understanding the impact of formulation processing operations on likely product performance.
- Managing Method Development (recorded)
Learn how an appropriate method for particle size analysis can be developed based on an understanding of why particle size analysis is important.
Series 2 - Focus on Pharma - Elemental Analysis
This webinar series will consider the requirements for elemental analysis for pharmaceutical intermediates and final dosage forms and also how X-Ray Fluorescence (XRF) offers a simple, robust alternative to existing methods such as ICP-OES, ICP-MS and AAS.
- Simplify your Workflow (recorded)
In this presentation, we considered why elemental analysis is required, reviewed the guidance provided in ICH Q3D and then examined the guidance provided in USP +lt;735>and EP 2.2.37 for the use of XRF.
- Reduce your Analytical Workload (17 Sept)
In this webinar we will consider how an appropriate method for XRF elemental analysis can be developed, including a live demonstration of the use of the technique.
Series 3 - Focus on Pharma - Solid Form Analysis Series
This webinar series will consider the guidance available regarding polymorph and crystallinity analysis for pharmaceutical products and how appropriate methods can be developed using the technique of X-Ray Powder Diffraction (XRPD).
- Advance your Analysis (recording available soon)
In this presentation we will discuss why a polymorph specification may be required, review the guidance provided in ICH Q6A and consider how XRPD can aid formulation developers in material selection and in understanding the impact of formulation processing operations on product performance.
- Targeting your Methods (26 Sept)
We will consider how an appropriate method for XRPD analysis can be developed and how various sample preparation techniques can influence it.
- Extend your understanding (10 Oct)
We will focus on the advanced analysis methods available using an XRPD system which can help with understanding the distribution of components within pharmaceutical dosage forms and can also provide a means of describing amorphous materials. This will be available soon.